×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DWTX – dogwood therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DWTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/15
09:00 am
dwtx
Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy
High
Report
Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy
3/18
09:18 am
dwtx
Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/18
08:30 am
dwtx
Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
2/20
08:03 am
dwtx
Dogwood Therapeutics (NASDAQ:DWTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
Dogwood Therapeutics (NASDAQ:DWTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
2/2
05:42 pm
dwtx
DWTX: Financing Secures Funding Through Phase 2b Data Readout [Yahoo! Finance]
Medium
Report
DWTX: Financing Secures Funding Through Phase 2b Data Readout [Yahoo! Finance]
2/2
09:17 am
dwtx
Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron® Phase 2b Trial, Top Line Results Anticipated in Q3 2026 [Yahoo! Finance]
Medium
Report
Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron® Phase 2b Trial, Top Line Results Anticipated in Q3 2026 [Yahoo! Finance]
2/2
08:30 am
dwtx
Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron® Phase 2b Trial, Top Line Results Anticipated in Q3 2026
Low
Report
Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron® Phase 2b Trial, Top Line Results Anticipated in Q3 2026
1/30
08:03 am
dwtx
Dogwood Therapeutics (NASDAQ:DWTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
Dogwood Therapeutics (NASDAQ:DWTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2025
08:45 am
DWTX
dogwood therapeutics, inc.
MISS
Report
-7.6%
dogwood therapeutics, inc.
8/13/2025
09:00 am
DWTX
dogwood therapeutics, inc.
MISS
Report
1.9%
dogwood therapeutics, inc.
5/8/2025
09:00 am
DWTX
dogwood therapeutics, inc.
MISS
Report
-1.3%
dogwood therapeutics, inc.
Date
Time
Symbol
Headline
Impact
3/26
09:00 am
dwtx
Form 8-K Dogwood Therapeutics, For: Mar 26
High
Report
Form 8-K Dogwood Therapeutics, For: Mar 26
3/18
04:32 pm
dwtx
Form 10-K Dogwood Therapeutics, For: Dec 31
High
Report
Form 10-K Dogwood Therapeutics, For: Dec 31
3/18
09:00 am
dwtx
Form 8-K Dogwood Therapeutics, For: Mar 18
Medium
Report
Form 8-K Dogwood Therapeutics, For: Mar 18
3/12
04:31 pm
dwtx
Form 8-K Dogwood Therapeutics, For: Mar 11
Low
Report
Form 8-K Dogwood Therapeutics, For: Mar 11
3/6
04:20 pm
dwtx
Form 4 Dogwood Therapeutics, For: Mar 05 Filed by: Grosswald Ralph
Medium
Report
Form 4 Dogwood Therapeutics, For: Mar 05 Filed by: Grosswald Ralph
3/6
04:19 pm
dwtx
Form 4 Dogwood Therapeutics, For: Mar 05 Filed by: Walsh Angela
Medium
Report
Form 4 Dogwood Therapeutics, For: Mar 05 Filed by: Walsh Angela
3/6
04:18 pm
dwtx
Form 4 Dogwood Therapeutics, For: Mar 05 Filed by: Gendreau Roger Michael
Medium
Report
Form 4 Dogwood Therapeutics, For: Mar 05 Filed by: Gendreau Roger Michael
3/6
04:17 pm
dwtx
Form 4 Dogwood Therapeutics, For: Mar 05 Filed by: Duncan Gregory Scott
Medium
Report
Form 4 Dogwood Therapeutics, For: Mar 05 Filed by: Duncan Gregory Scott
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: